학술논문
Tolerance-based capecitabine dose escalation after DPYD genotype-guided dosing in heterozygote DPYD variant carriers: a single-center observational study.
Document Type
Article
Author
Source
Anti-Cancer Drugs; Apr2019, Vol. 30 Issue 4, p410-415, 6p
Subject
Language
ISSN
09594973